AG真人官方

Michael A. Pisetsky, SVP, Ops & Adm and Chief Legal Officer of SI-BONE, Inc. (SIBN), reported sales on 08/18/2025 that were executed to satisfy tax withholding obligations on vesting restricted stock units through a "sell-to-cover" process. The filing shows two non-derivative dispositions: 1,851 shares sold at a weighted-average price of $15.6524 and 1,478 shares sold at a weighted-average price of $15.6171, with transaction prices ranging from $15.49 to $15.80. After these transactions the reporting person beneficially owned 258,352 shares. The filing discloses that 138,504 of those shares are issuable upon settlement of restricted stock units, each representing a contingent right to one share.

Insider sale to cover taxes: SI-BONE Chief Financial Officer Anshul Maheshwari reported sales of common stock on 08/18/2025 to satisfy tax withholding on vested restricted stock units. The Form 4 shows two sell-to-cover transactions: 1,276 shares sold at a weighted average price of $15.5924 and 2,185 shares sold at a weighted average price of $15.5538, reducing beneficial ownership to 216,630 and 214,445 shares respectively as reported for each line. The report notes 156,983 shares remain issuable upon settlement of outstanding restricted stock units. The filing states these sales were non-discretionary and executed in multiple trades across price ranges disclosed in the footnotes.

SI-BONE insider sale tied to RSU tax withholding: Laura A. Francis, who serves as both Chief Executive Officer and a director, reported multiple dispositions of her common stock to satisfy tax withholding on vested restricted stock units. The transactions on 08/18/2025 consisted of five grouped sales totaling 11,343 shares disposed at weighted-average prices in the roughly $15.52鈥�$15.83 range, producing the reported per-trade weighted averages shown. After these transactions the filing shows Ms. Francis directly beneficially owns 419,704 shares and indirectly owns 362,141 shares through The David & Laura Joint Rev Tr., with 396,297 shares included as shares issuable upon settlement of RSUs.

OrbiMed files Amendment No. 5 to a Schedule 13G/A reporting ownership in SI-BONE, Inc. (SIBN). OrbiMed Capital LLC reports beneficial ownership of 2,184,200 shares, representing 5.1% of SI-BONE's common stock, with sole voting and dispositive power over those shares. OrbiMed Advisors LLC reports beneficial ownership of 394,779 shares, representing 0.9%, with shared voting and dispositive power. Together the reporting persons hold 6.0% of the class on behalf of other persons and exercise investment and voting power through a management committee of three named members. The filing states the shares were acquired in the ordinary course of business and not for the purpose of changing control.

Champlain Investment Partners, LLC reported beneficial ownership of 2,140,074 shares of SI-BONE, Inc. common stock, representing 5.0% of the outstanding class. The filing states Champlain is organized in Vermont and acts as an investment adviser.

The report breaks down voting and dispositive power: 1,368,619 shares are listed as sole voting power and 2,140,074 shares as sole dispositive power. The filer certifies the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

John G. Freund, a director of SI-BONE, Inc. (SIBN), reported insider sales and remaining holdings. The Form 4 shows a sale (Code S) of 12,132 shares on 08/08/2025 at a weighted-average price of $15.9906, executed in multiple trades with prices ranging from $15.80 to $16.3950. The filing also records a reported disposition of 43,301 shares which includes 8,675 restricted stock units.

The report shows 91,767 shares beneficially owned following the reported transaction(s), held indirectly by John Freund Family Partnership IV, L.P. The filing notes the Reporting Person is a general partner of that Family LP and disclaims beneficial ownership except to the extent of pecuniary interest.

SI-BONE (SIBN) 鈥� Form 4 insider transaction

Director Jeffrey W. Dunn executed an automatic 鈥渟ell-to-cover鈥� on 08/04/2025 related to the vesting of restricted stock units. To satisfy tax-withholding, he sold 293 common shares at a weighted-average price of $17.3743 (price range $17.36-$17.39). The sale was executed under Rule 10b5-1 and is classified as code 鈥淪鈥�, indicating a non-discretionary sale for tax purposes.

Post-transaction holdings are 11,647 shares held directly and 117,827 shares held indirectly via The Jeffrey W. Dunn Living Trust. The indirect total includes 11,124 un-settled RSUs. No derivative securities were reported.

The transaction represents less than 0.1% of Dunn鈥檚 aggregate ownership and does not signal a strategic shift or change in insider sentiment.